Viewing nowCombinationTwin Down Tablets 80/5 mg
Telmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.

MFDS item code 201804759 · Approved 2018.11.29 · Insurance code 622803340
Treatment of essential hypertension not controlled with amlodipine or telmisartan monotherapy
This medication is used to effectively lower blood pressure in patients with essential hypertension who have difficulty controlling blood pressure with either amlodipine or telmisartan monotherapy.
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before starting this drug; however, if blood pressure is not controlled with the individual components as described below, switching directly to this drug may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this drug 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients who should be administered this drug with caution’). In patients 75 years of age or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
○ Pediatric patients: The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication should not be used during pregnancy, particularly in the second and third trimesters, as it may pose serious risks to the fetus. If pregnancy is confirmed, the use of this medication should be discontinued as soon as possible. Administration is not recommended for those who are allergic to the active ingredients or similar medications, pregnant or potentially pregnant women, nursing mothers, individuals with obstructive biliary disease, severe liver impairment, certain cardiac conditions, severe hypotension, shock, unstable heart failure after acute myocardial infarction, and individuals with specific genetic issues. Additionally, patients with diabetes or moderate to severe kidney dysfunction should not take this medication in conjunction with other medications that contain specific ingredients. Particular caution is required for patients with primary hyperaldosteronism, certain heart valve diseases, liver impairment, gastrointestinal diseases, renal artery hypertension, patients on dialysis for kidney failure, and elderly individuals. This medication may commonly cause side effects such as dizziness, peripheral edema, and blood pressure drops, and in severe cases, fainting or heart problems may occur, so caution is advised. Pregnant or nursing women should not take this medication, and those planning pregnancy are recommended to switch to other safe antihypertensive treatments. This medication may interact with various other drugs; therefore, patients should consult healthcare professionals if they are taking other medications. Elderly patients may react more sensitively to this medication, and it is safer to start at a lower dose and gradually increase it when they begin taking it. In cases of overdose, serious symptoms such as hypotension, dizziness, and heart rhythm abnormalities may occur, necessitating immediate contact with a healthcare facility. Finally, this medication should be stored in a safe place out of reach of children, and it is advisable that the packaging be opened right before use.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that protects it from light. Additionally, it should be kept at a temperature between 1 degree and 30 degrees Celsius to maintain its effectiveness.
A double convex oval tablet that is white and light gray in color.
30 Tablets (10 Tablets/PTP X 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.